{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:16:19Z","timestamp":1787886979095,"version":"build-2784847793"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cancer is characterized by chromosomal instability (CIN), which leads to tumor heterogeneity and other malignant features. CIN is caused by abnormal centromere and kinetochore function, which results in aneuploidy, rearrangements, and micronucleus production. Centromere and kinetochore gene misexpression plays a vital role in tumor progression. Here we show that Centromere Protein T (CENPT) is highly expressed in renal carcinoma (RCC) and promotes the tumor proliferation and metastasis of RCC. CENPT is found to be critical for regulating the glutathione (GSH) metabolism pathway because it interacts with \u03b3-glutamyl-cysteine ligase catalytic subunit (GCLC), consequently reducing reactive oxygen species levels and inhibiting ferroptosis. Mechanistically, CENPT increases the catalytic activity of GCLC by directly binding to GCLC \u2206213-424aa competitively with glutamate-cysteine ligase modifier subunit (GCLM), consequently induces the GSH synthesis. In turn, GSH increases CENPT expression via transcriptional regulation mediated by the transcription factor ATF2, forming a CENPT-GCLC-GSH feedback loop that enhances the pro-carcinogenic effect of this axis in RCC. Our study identifies CENPT a potential target for RCC via forming a CENPT-GCLC-GSH feedback loop to inhibit ferroptosis. This may support a promising treatment strategy for RCC.<\/jats:p>","DOI":"10.1038\/s41419-025-07848-x","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T13:10:50Z","timestamp":1752325850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["CENPT prevents renal cell carcinoma against ferroptosis by enhancing the synthesis of glutathione"],"prefix":"10.1038","volume":"16","author":[{"given":"Han","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0892-6102","authenticated-orcid":false,"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-4200","authenticated-orcid":false,"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"7848_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"7848_CR2","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","volume":"387","author":"U Capitanio","year":"2016","unstructured":"Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387:894\u2013906.","journal-title":"Lancet"},{"key":"7848_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","volume":"16","author":"WM Linehan","year":"2019","unstructured":"Linehan WM, Ricketts CJ. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019;16:539\u201352.","journal-title":"Nat Rev Urol"},{"key":"7848_CR4","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1001\/jamaoncol.2019.2187","volume":"5","author":"SL Topalian","year":"2019","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with Nivolumab. JAMA Oncol. 2019;5:1411\u201320.","journal-title":"JAMA Oncol"},{"key":"7848_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15279-9","volume":"11","author":"WHM Hoevenaar","year":"2020","unstructured":"Hoevenaar WHM, Janssen A, Quirindongo AI, Ma H, Klaasen SJ, Teixeira A, et al. Degree and site of chromosomal instability define its oncogenic potential. Nature Commun. 2020;11:1501.","journal-title":"Nature Commun"},{"key":"7848_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/25292","volume":"396","author":"C Lengauer","year":"1998","unstructured":"Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643\u20139.","journal-title":"Nature"},{"key":"7848_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12619","volume":"7","author":"W Zhang","year":"2016","unstructured":"Zhang W, Mao J-H, Zhu W, Jain AK, Liu K, Brown JB, et al. Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy. Nature Commun. 2016;7:12619.","journal-title":"Nature Commun"},{"key":"7848_CR8","doi-asserted-by":"publisher","first-page":"101703","DOI":"10.1016\/j.tranon.2023.101703","volume":"34","author":"RK Aldwaik","year":"2023","unstructured":"Aldwaik RK, Shian D, Thapa R, Vasudevan S, Ashqar MA-A, Reich E, et al. Overexpressed kinetochore genes are used by cancer cells as genome destabilizers and transformation catalysts. Translational Oncol. 2023;34:101703.","journal-title":"Translational Oncol"},{"key":"7848_CR9","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1038\/onc.2014.344","volume":"34","author":"Z Shaukat","year":"2015","unstructured":"Shaukat Z, Liu D, Choo A, Hussain R, O\u2019Keefe L, Richards R, et al. Chromosomal instability causes sensitivity to metabolic stress. Oncogene. 2015;34:4044\u201355.","journal-title":"Oncogene"},{"key":"7848_CR10","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1083\/jcb.201804161","volume":"217","author":"A Bansal","year":"2018","unstructured":"Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;217:2291\u20138.","journal-title":"J Cell Biol"},{"key":"7848_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0968-0004(88)90148-X","volume":"13","author":"A Meister","year":"1988","unstructured":"Meister A. On the discovery of glutathione. Trends Biochem Sci. 1988;13:185\u20138.","journal-title":"Trends Biochem Sci"},{"key":"7848_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","volume":"30","author":"SC Lu","year":"2009","unstructured":"Lu SC. Regulation of glutathione synthesis. Mol Asp Med. 2009;30:42\u201359.","journal-title":"Mol Asp Med"},{"key":"7848_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.119","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim J, Kim J, Bae JS. ROS homeostasis and metabolism: a critical liaison for cancer therapy. Exp Mol Med. 2016;48:e269.","journal-title":"Exp Mol Med"},{"key":"7848_CR14","doi-asserted-by":"crossref","unstructured":"Xiao Y, Meierhofer D. Glutathione metabolism in renal cell carcinoma progression and implications for therapies. Int J Mol Sci. 2019;20:3672.","DOI":"10.3390\/ijms20153672"},{"key":"7848_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc1046","volume":"3","author":"SP Hussain","year":"2003","unstructured":"Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer. 2003;3:276\u201385.","journal-title":"Nat Rev Cancer"},{"key":"7848_CR16","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1073\/pnas.67.3.1248","volume":"67","author":"M Orlowski","year":"1970","unstructured":"Orlowski M, Meister A. The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci USA. 1970;67:1248\u201355.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7848_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mam.2008.08.009","volume":"30","author":"CC Franklin","year":"2009","unstructured":"Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Asp Med. 2009;30:86\u201398.","journal-title":"Mol Asp Med"},{"key":"7848_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3892\/br.2014.359","volume":"2","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Yuan J, Zhang Y, Jin X. Altered glutamate cysteine ligase expression and activity in renal cell carcinoma. Biomed Rep. 2014;2:831\u20134.","journal-title":"Biomed Rep"},{"key":"7848_CR19","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","volume":"37","author":"H Miess","year":"2018","unstructured":"Miess H, Dankworth B, Gouw AM, Rosenfeldt M, Schmitz W, Jiang M, et al. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene. 2018;37:5435\u201350.","journal-title":"Oncogene"},{"key":"7848_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1055\/s-2007-1007167","volume":"18","author":"M Ookhtens","year":"1998","unstructured":"Ookhtens M, Kaplowitz N. Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis. 1998;18:313\u201329.","journal-title":"Semin Liver Dis"},{"key":"7848_CR21","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830:3143\u201353.","journal-title":"Biochim Biophys Acta"},{"key":"7848_CR22","doi-asserted-by":"crossref","unstructured":"Yan Y, Gan B. Hyperoxidized PRDX3 as a specific ferroptosis marker. Life Metab. 2023;2:load042.","DOI":"10.1093\/lifemeta\/load042"},{"key":"7848_CR23","doi-asserted-by":"publisher","first-page":"11756","DOI":"10.18632\/oncotarget.7598","volume":"7","author":"M Hasegawa","year":"2016","unstructured":"Hasegawa M, Takahashi H, Rajabi H, Alam M, Suzuki Y, Yin L, et al. Functional interactions of the cystine\/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget. 2016;7:11756\u201369.","journal-title":"Oncotarget"},{"key":"7848_CR24","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00432-018-2740-3","volume":"144","author":"J Nie","year":"2018","unstructured":"Nie J, Lin B, Zhou M, Wu L, Zheng T. Role of ferroptosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2018;144:2329\u201337.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7848_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrc1714","volume":"5","author":"GJ Kops","year":"2005","unstructured":"Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer. 2005;5:773\u201385.","journal-title":"Nat Rev Cancer"},{"key":"7848_CR26","first-page":"64","volume":"1866","author":"K Tanaka","year":"2016","unstructured":"Tanaka K, Hirota T. Chromosomal instability: A common feature and a therapeutic target of cancer. Biochim Biophys Acta. 2016;1866:64\u201375.","journal-title":"Biochim Biophys Acta"},{"key":"7848_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-genet-102108-134310","volume":"43","author":"MR Przewloka","year":"2009","unstructured":"Przewloka MR, Glover DM. The kinetochore and the centromere: a working long distance relationship. Annu Rev Genet. 2009;43:439\u201365.","journal-title":"Annu Rev Genet"},{"key":"7848_CR28","doi-asserted-by":"crossref","unstructured":"Musacchio A, Desai A. A molecular view of kinetochore assembly and function. Biology. 2017;6:5.","DOI":"10.3390\/biology6010005"},{"key":"7848_CR29","doi-asserted-by":"publisher","first-page":"100695","DOI":"10.1016\/j.jhepr.2023.100695","volume":"5","author":"W Su","year":"2023","unstructured":"Su W, Gao W, Zhang R, Wang Q, Li L, Bu Q, et al. TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling. JHEP Rep. 2023;5:100695.","journal-title":"JHEP Rep"},{"key":"7848_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"7848_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","volume":"27","author":"BR Stockwell","year":"2020","unstructured":"Stockwell BR, Jiang X. The chemistry and biology of ferroptosis. Cell Chem Biol. 2020;27:365\u201375.","journal-title":"Cell Chem Biol"},{"key":"7848_CR32","doi-asserted-by":"publisher","first-page":"108373","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa I, Barbosa DJ, Benfeito S, Silva V, Chavarria D, Borges F, et al. Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther. 2023;244:108373.","journal-title":"Pharmacol Ther"},{"key":"7848_CR33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.bcp.2007.02.003","volume":"74","author":"Y Yang","year":"2007","unstructured":"Yang Y, Chen Y, Johansson E, Schneider SN, Shertzer HG, Nebert DW, et al. Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase. Biochem Pharm. 2007;74:372\u201381.","journal-title":"Biochem Pharm"},{"key":"7848_CR34","doi-asserted-by":"publisher","first-page":"20578","DOI":"10.1016\/S0021-9258(20)80764-9","volume":"268","author":"CS Huang","year":"1993","unstructured":"Huang CS, Anderson ME, Meister A. Amino acid sequence and function of the light subunit of rat kidney gamma-glutamylcysteine synthetase. J Biol Chem. 1993;268:20578\u201383.","journal-title":"J Biol Chem"},{"key":"7848_CR35","doi-asserted-by":"publisher","first-page":"19675","DOI":"10.1016\/S0021-9258(19)36569-X","volume":"268","author":"CS Huang","year":"1993","unstructured":"Huang CS, Chang LS, Anderson ME, Meister A. Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J Biol Chem. 1993;268:19675\u201380.","journal-title":"J Biol Chem"},{"key":"7848_CR36","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S0891-5849(99)00176-8","volume":"27","author":"OW Griffith","year":"1999","unstructured":"Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med. 1999;27:922\u201335.","journal-title":"Free Radic Biol Med"},{"key":"7848_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.gendis.2021.04.008","volume":"9","author":"M Chen","year":"2022","unstructured":"Chen M, Liu Y, Yang Y, Qiu Y, Wang Z, Li X, et al. Emerging roles of activating transcription factor (ATF) family members in tumourigenesis and immunity: Implications in cancer immunotherapy. Genes Dis. 2022;9:981\u201399.","journal-title":"Genes Dis"},{"key":"7848_CR38","doi-asserted-by":"crossref","unstructured":"Ioannou I, Chatziantoniou A, Drenios C, Christodoulou P, Kourti M, Zaravinos A. Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Kidney Cancers. Int J Mol Sci. 2023;24:6577.","DOI":"10.3390\/ijms24076577"},{"key":"7848_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2443.2004.00705.x","volume":"9","author":"C Obuse","year":"2004","unstructured":"Obuse C, Yang H, Nozaki N, Goto S, Okazaki T, Yoda K. Proteomics analysis of the centromere complex from HeLa interphase cells: UV-damaged DNA binding protein 1 (DDB-1) is a component of the CEN-complex, while BMI-1 is transiently co-localized with the centromeric region in interphase. Genes Cells. 2004;9:105\u201320.","journal-title":"Genes Cells"},{"key":"7848_CR40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ncb1397","volume":"8","author":"DR Foltz","year":"2006","unstructured":"Foltz DR, Jansen LE, Black BE, Bailey AO, Yates JR 3rd, Cleveland DW. The human CENP-A centromeric nucleosome-associated complex. Nat Cell Biol. 2006;8:458\u201369. p.","journal-title":"Nat Cell Biol"},{"key":"7848_CR41","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1101\/gad.1301805","volume":"19","author":"A Selvaraj","year":"2005","unstructured":"Selvaraj A, Balamurugan K, Yepiskoposyan H, Zhou H, Egli D, Georgiev O, et al. Metal-responsive transcription factor (MTF-1) handles both extremes, copper load and copper starvation, by activating different genes. Genes Dev. 2005;19:891\u20136.","journal-title":"Genes Dev"},{"key":"7848_CR42","first-page":"21158","volume":"277","author":"H Jardine","year":"2002","unstructured":"Jardine H, MacNee W, Donaldson K, Rahman I. Molecular mechanism of transforming growth factor (TGF)-beta1-induced glutathione depletion in alveolar epithelial cells. Involvement AP-1\/ARE Fra-1 J Biol Chem. 2002;277:21158\u201366.","journal-title":"Involvement AP-1\/ARE Fra-1 J Biol Chem"},{"key":"7848_CR43","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1124\/mol.107.040634","volume":"73","author":"Y Fu","year":"2008","unstructured":"Fu Y, Zheng S, Lu SC, Chen A. Epigallocatechin-3-gallate inhibits growth of activated hepatic stellate cells by enhancing the capacity of glutathione synthesis. Mol Pharm. 2008;73:1465\u201373.","journal-title":"Mol Pharm"},{"key":"7848_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39901-8","volume":"14","author":"Z Yang","year":"2023","unstructured":"Yang Z, Zou S, Zhang Y, Zhang J, Zhang P, Xiao L, et al. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis. Nat Commun. 2023;14:4193.","journal-title":"Nat Commun"},{"key":"7848_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2020.12.007","volume":"33","author":"YP Kang","year":"2021","unstructured":"Kang YP, Mockabee-Macias A, Jiang C, Falzone A, Prieto-Farigua N, Stone E, et al. Non-canonical Glutamate-Cysteine ligase activity protects against ferroptosis. Cell Metab. 2021;33:174\u2013189.e7.","journal-title":"Cell Metab"},{"key":"7848_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0162-3109(89)90020-9","volume":"18","author":"DL Hamilos","year":"1989","unstructured":"Hamilos DL, Zelarney P, Mascali JJ. Lymphocyte proliferation in glutathione-depleted lymphocytes: direct relationship between glutathione availability and the proliferative response. Immunopharmacology. 1989;18:223\u201335.","journal-title":"Immunopharmacology"},{"key":"7848_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/jcp.1041630316","volume":"163","author":"M Poot","year":"1995","unstructured":"Poot M, Teubert H, Rabinovitch PS, Kavanagh TJ. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J Cell Physiol. 1995;163:555\u201360.","journal-title":"J Cell Physiol"},{"key":"7848_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF00686114","volume":"34","author":"RT Mulcahy","year":"1994","unstructured":"Mulcahy RT, Bailey HH, Gipp JJ. Up-regulation of gamma-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levels. Cancer Chemother Pharm. 1994;34:67\u201371.","journal-title":"Cancer Chemother Pharm"},{"key":"7848_CR49","doi-asserted-by":"publisher","first-page":"31075","DOI":"10.1074\/jbc.273.47.31075","volume":"273","author":"Y Yamane","year":"1998","unstructured":"Yamane Y, Furuichi M, Song R, Van NT, Mulcahy RT, Ishikawa T, et al. Expression of multidrug resistance protein\/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol Chem. 1998;273:31075\u201385.","journal-title":"J Biol Chem"},{"key":"7848_CR50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/mutage\/gen073","volume":"24","author":"MM Cortes-Wanstreet","year":"2009","unstructured":"Cortes-Wanstreet MM, Giedzinski E, Limoli CL, Luderer U. Overexpression of glutamate-cysteine ligase protects human COV434 granulosa tumour cells against oxidative and gamma-radiation-induced cell death. Mutagenesis. 2009;24:211\u201324.","journal-title":"Mutagenesis"},{"key":"7848_CR51","doi-asserted-by":"publisher","first-page":"113380","DOI":"10.1016\/j.ecoenv.2022.113380","volume":"234","author":"S Ran","year":"2022","unstructured":"Ran S, Gao X, Ma M, Zhang J, Li S, Zhang M, et al. NaAsO(2) decreases GSH synthesis by inhibiting GCLC and induces apoptosis through Hela cell mitochondrial damage, mediating the activation of the NF-\u03baB\/miR-21 signaling pathway. Ecotoxicol Environ Saf. 2022;234:113380.","journal-title":"Ecotoxicol Environ Saf"},{"key":"7848_CR52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/toxsci\/61.2.218","volume":"61","author":"AC Walsh","year":"2001","unstructured":"Walsh AC, Feulner JA, Reilly A. Evidence for functionally significant polymorphism of human glutamate cysteine ligase catalytic subunit: association with glutathione levels and drug resistance in the National Cancer Institute tumor cell line panel. Toxicol Sci. 2001;61:218\u201323.","journal-title":"Toxicol Sci"},{"key":"7848_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000134447","volume":"75","author":"AC Walsh","year":"1996","unstructured":"Walsh AC, Li W, Rosen DR, Lawrence DA. Genetic mapping of GLCLC, the human gene encoding the catalytic subunit of gamma-glutamyl-cysteine synthetase, to chromosome band 6p12 and characterization of a polymorphic trinucleotide repeat within its 5\u2019 untranslated region. Cytogenet Cell Genet. 1996;75:14\u20136.","journal-title":"Cytogenet Cell Genet"},{"key":"7848_CR54","doi-asserted-by":"publisher","first-page":"16621","DOI":"10.1073\/pnas.0706778104","volume":"104","author":"R Gysin","year":"2007","unstructured":"Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, et al. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci USA. 2007;104:16621\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7848_CR55","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/01.CIR.0000091255.63645.98","volume":"108","author":"S Nakamura","year":"2003","unstructured":"Nakamura S, Sugiyama S, Fujioka D, Kawabata K, Ogawa H, Kugiyama K. Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function. Circulation. 2003;108:1425\u20137.","journal-title":"Circulation"},{"key":"7848_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1096\/fj.00-0445fje","volume":"15","author":"ZZ Huang","year":"2001","unstructured":"Huang ZZ, Chen C, Zeng Z, Yang H, Oh J, Chen L, et al. Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. Faseb j. 2001;15:19\u201321.","journal-title":"Faseb j"},{"key":"7848_CR57","doi-asserted-by":"publisher","first-page":"102564","DOI":"10.1016\/j.redox.2022.102564","volume":"59","author":"X Xu","year":"2023","unstructured":"Xu X, Li Y, Wu Y, Wang M, Lu Y, Fang Z, et al. Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer. Redox Biol. 2023;59:102564.","journal-title":"Redox Biol"},{"key":"7848_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01697-8","volume":"20","author":"J Liu","year":"2020","unstructured":"Liu J, Li K, Wang R, Chen S, Wu J, Li X, et al. The interplay between ATF2 and NEAT1 contributes to lung adenocarcinoma progression. Cancer Cell Int. 2020;20:594.","journal-title":"Cancer Cell Int"},{"key":"7848_CR59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-016-0383-2","volume":"35","author":"DS Wu","year":"2016","unstructured":"Wu DS, Chen C, Wu ZJ, Liu B, Gao L, Yang Q, et al. ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma. J Exp Clin Cancer Res. 2016;35:108.","journal-title":"J Exp Clin Cancer Res"},{"key":"7848_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01359-7","volume":"22","author":"A Giannoudis","year":"2020","unstructured":"Giannoudis A, Malki MI, Rudraraju B, Mohhamed H, Menon S, Liloglou T, et al. Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. Breast Cancer Res. 2020;22:126.","journal-title":"Breast Cancer Res"},{"key":"7848_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23:27\u201347.","journal-title":"Cell Metab"},{"key":"7848_CR62","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7848_CR63","doi-asserted-by":"publisher","first-page":"102349","DOI":"10.1016\/j.redox.2022.102349","volume":"53","author":"Y Xu","year":"2022","unstructured":"Xu Y, Li Y, Li J, Chen W. Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation. Redox Biol. 2022;53:102349.","journal-title":"Redox Biol"},{"key":"7848_CR64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 2022;42:88\u2013116.","journal-title":"Cancer Commun (Lond)"},{"key":"7848_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022;13:2206.","journal-title":"Nat Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07848-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T08:00:58Z","timestamp":1757232058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07848-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7848"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07848-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the datasets were retrieved from the published literature, so it was confirmed that all written informed consent was obtained. Reusable datasets for our analysis comply with relevant ethical regulations. The studies in which human prostate tumor samples were collected were approved by the ethical committees of the Affiliated Hospital of Qingdao University. Written consent was obtained from all patients and healthcare workers. For mouse studies, all procedures were approved by the Ethics Committee of the Medical Animal Laboratory of the Affiliated Hospital of Qingdao University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement and consent to participate"}}],"article-number":"517"}}